Categories
  Encyclosphere.org ENCYCLOREADER
  supported by EncyclosphereKSF

Izencitinib

Topic: Chemistry

 From HandWiki - Reading time: 1 min

Izencitinib (TD-1473) is a drug which acts as a pan-Janus kinase inhibitor, binding with high affinity at all three subtypes JAK1, JAK2 and JAK3. It is taken orally and was developed to be gut selective with minimal absorption into the rest of the body, allowing targeting of inflammatory bowel disease but with reduced side effects compared to other similar drugs.[1][2]

See also

References

  1. ↑ "JAK selectivity: more precision less troubles". Expert Review of Gastroenterology & Hepatology 14 (9): 789–796. September 2020. doi:10.1080/17474124.2020.1780120. PMID 32520647. 
  2. ↑ "Gut-Selective Design of Orally Administered Izencitinib (TD-1473) Limits Systemic Exposure and Effects of Janus Kinase Inhibition in Nonclinical Species". Toxicological Sciences 186 (2): 323–337. March 2022. doi:10.1093/toxsci/kfac002. PMID 35134999. 



Retrieved from "https://handwiki.org/wiki/index.php?title=Chemistry:Izencitinib&oldid=4037642"
Licensed under CC BY-SA 3.0 | Source: https://handwiki.org/wiki/Chemistry:Izencitinib
1 views |
↧ Download this article as ZWI file
Encyclosphere.org EncycloReader is supported by the EncyclosphereKSF